Latest Updates
-
Horoscope for Today April 09, 2026 - Steady Progress from Mindful Choices -
Thick Masala Restaurant Style Mutton Gravy Recipe -
Thinking of Getting Inked? Here’s What The Expert Wants You To Know -
Hakka Noodles Recipe: Master the Street Style Wok Toss Trick -
Celeb Beauty Routine: No 10-Step Routine—Udne Ki Aasha Lead Neha Harsora Keeps It Simple -
“Prevention Is the Real Cure”: Key Takeaways from BoldSky’s World Health Day Panel -
Veg Sandwich Recipe: Your Quick Filling Lunch Idea -
Hair Hacks 101: This Heatless Soft Curls Trick Is All You Need to Know -
Kerala’s Dreamy Water Bridge Is All Over Instagram—But It’s Not Safe to Visit -
Samay Raina Comeback in ‘Still Alive’: Calls Out Sunil Pal, Addresses Allahbadia Joke Fallout
An Aspirin A Day Keeps Cancer At Bay!

A new research has suggested that aspirin in cancer treatment can cut death rate.
Brit researchers come up that death due to cancer can be combated with aspirin. It is supposed to cut down overall death rates by one third in five years of use. Longer the period of using aspirin, better the the protection from cancer. It was about 50 percent for some users.
In the view of experts, that aspirin worked well with healthy people of middle age healthy middle-age around 45 to 50 years who are accustomed to the use of low doses of aspirin for over 20-30 years were the most benefited, as cancer seems to show up with age.
It even helps to keep away heart attacks and strokes in people who have not been diagonised with cardiovascular problems, with a dosage of 75mg, which is a quarter of a standard 300mg tablet.
The research also revealed the relieving fact that death rate fell by 34 percent for all cancer types and by 54 percent for gastrointestinal cancers. The rick of cancer is curbed by 20 percent in groups alanysed for all solid cancers and 35 percent lower for gastrointestinal cancers.
Positive results started emerging after 5years in cancer like Oesophageal (gullet), pancreatic, brain and some forms of lung cancer. However it took about 10 years for results to emerge in stomach and colorectal cancer and 15 years for prostate cancer.
The latest research headed by Peter Rothwell, of the John Radcliffe Hospital, Oxford, who headed the is convinced the basic rules have changed.
"These findings provide the first proof in man that aspirin reduces deaths due to several common cancers," the Daily Mail quoted him as saying.
"Previous guidelines have rightly cautioned that in healthy middle-aged people the small risk of bleeding on aspirin partly offsets the benefits from prevention of strokes and heart attacks, but the reductions in deaths due to several common cancers will now alter this balance for many people," he said.
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.



Click it and Unblock the Notifications











